by admin | Jan 23, 2018 | News & Opinions
MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit,...
by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
by Bernard Siegel | Apr 10, 2017 | Bioethics, News & Opinions, Policy
Sheef /ʃiːf/ noun acronym. Synthetic Human Entity with Embryo-like Features. “Change is avalanching upon our heads and most people are grotesquely unprepared to cope with it.” Alvin Toffler (1970)- Future Shock Stem cell engineering has leaped forward so fast that...
by Bernard Siegel | Mar 16, 2017 | News & Opinions, Science
The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...
by Admin | Oct 12, 2016 | News & Opinions, Science
Scientists in Japan have used cardiac muscle cells derived from the stem cells of a monkey to heal the damaged hearts of five other monkeys. The recipient monkeys showed improved cardiac contractile function at 4 and 12 weeks after transplantation, and no evidence of...
